Healthpeak Properties, Inc. $DOC Shares Purchased by Fifth Third Bancorp

Fifth Third Bancorp increased its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 1,366.1% in the 1st quarter, Holdings Channel.com reports. The fund owned 721,724 shares of the real estate investment trust’s stock after acquiring an additional 672,498 shares during the quarter. Fifth Third Bancorp’s holdings in Healthpeak Properties were worth $11,858,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. Sequoia Financial Advisors LLC raised its position in shares of Healthpeak Properties by 12.5% during the 1st quarter. Sequoia Financial Advisors LLC now owns 143,920 shares of the real estate investment trust’s stock worth $2,365,000 after purchasing an additional 16,001 shares during the last quarter. Hsbc Holdings PLC lifted its stake in Healthpeak Properties by 3.7% in the 1st quarter. Hsbc Holdings PLC now owns 3,384,027 shares of the real estate investment trust’s stock valued at $55,676,000 after buying an additional 121,425 shares in the last quarter. Summit Securities Group LLC boosted its holdings in Healthpeak Properties by 354.9% in the 1st quarter. Summit Securities Group LLC now owns 4,690 shares of the real estate investment trust’s stock worth $77,000 after buying an additional 3,659 shares during the last quarter. Beacon Financial Group boosted its holdings in Healthpeak Properties by 16.0% in the 1st quarter. Beacon Financial Group now owns 14,650 shares of the real estate investment trust’s stock worth $241,000 after buying an additional 2,016 shares during the last quarter. Finally, Kestra Advisory Services LLC increased its stake in Healthpeak Properties by 96.3% during the 1st quarter. Kestra Advisory Services LLC now owns 110,985 shares of the real estate investment trust’s stock worth $1,823,000 after buying an additional 54,436 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Stock Performance

NYSE DOC opened at $21.70 on Wednesday. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. The company has a market cap of $14.96 billion, a P/E ratio of 67.80, a P/E/G ratio of 3.38 and a beta of 1.02. The stock has a 50-day moving average of $20.31 and a two-hundred day moving average of $18.12. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $22.13.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business had revenue of $752.95 million for the quarter, compared to analysts’ expectations of $694.59 million. During the same quarter in the prior year, the company earned $0.46 earnings per share. The business’s quarterly revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, analysts anticipate that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be paid a $0.1017 dividend. This represents a c) annualized dividend and a yield of 5.6%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s dividend payout ratio is currently 381.25%.

Insider Activity

In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.23% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages recently commented on DOC. Barclays initiated coverage on Healthpeak Properties in a research report on Tuesday, July 7th. They set an “equal weight” rating and a $23.00 price target for the company. Mizuho upped their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, July 6th. Raymond James Financial assumed coverage on shares of Healthpeak Properties in a research report on Wednesday, June 17th. They issued a “market perform” rating for the company. Citigroup increased their target price on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Four analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $20.50.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.